Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I read this whole thread thinking I was on /c/TheOnion, not /c/NotTheOnion, and thought the joke just went over your head.
Wow, it’s really not the Onion. What a headline. I gave the article a brief skim and it seems to be sarcasm-free.
!pukedtheonion